Cargando…

Secondary skin involvement in gastric diffuse large B-cell lymphoma treated with chidamide: A case report

RATIONALE: Diffuse large B-cell lymphoma (DLBCL) is a neoplasm of large B lymphoid cells that exhibits diffuse growth patterns. Patients may present with nodal and/or extranodal disease. The most common extranodal site is the gastrointestinal tract, while skin is less common. PATIENT CONCERNS: We re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Dan, Zhang, Wei-Ping, Yang, Jian-Min, He, Miao-Xia, Cheng, Chao, Chen, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310597/ https://www.ncbi.nlm.nih.gov/pubmed/30544372 http://dx.doi.org/10.1097/MD.0000000000013093

Ejemplares similares

Sintilimab and Chidamide for Refractory Transformed Diffuse Large B Cell Lymphoma: A Case Report and A Literature Review
por: Chen, Chao, et al.
Publicado: (2021)

Chidamide combined with ibrutinib improved the prognosis of primary bone marrow diffuse large B cell lymphoma
por: Tian, Chen, et al.
Publicado: (2020)

Chidamide in the treatment of peripheral T-cell lymphoma
por: Chan, Thomas S, et al.
Publicado: (2017)

Chidamide and sintilimab combination in diffuse large B-cell lymphoma progressing after chimeric antigen receptor T therapy
por: Hao, Yuan-Yuan, et al.
Publicado: (2022)

Effect of chidamide on treating hepatosplenic T-cell lymphoma: A case report
por: Wang, Xing-Tong, et al.
Publicado: (2020)

Ovary involvement of diffuse large B-cell lymphoma
por: Hu, Rong, et al.
Publicado: (2012)

Gastric Adenocarcinoma Secondary to Primary Gastric Diffuse Large B-cell Lymphoma
por: Sakr, Riwa, et al.
Publicado: (2017)

Novel HDAC inhibitor Chidamide synergizes with Rituximab to inhibit diffuse large B-cell lymphoma tumour growth by upregulating CD20
por: Guan, Xu-Wen, et al.
Publicado: (2020)

The Synergistic Antitumor Activity of Chidamide in Combination with Bortezomib on Gastric Cancer
por: Zhang, Wanjun, et al.
Publicado: (2020)

Secondary Cutaneous Involvement in Follicular Diffuse Lymphoma Treated with Helical Tomotherapy
por: Dar, A. Rashid, et al.
Publicado: (2017)

Preclinical Evaluation of the HDAC Inhibitor Chidamide in Transformed Follicular Lymphoma
por: Zhong, Mengya, et al.
Publicado: (2021)

Central nervous system involvement of primary renal lymphoma with diffuse large B-cell type lymphoma
por: Hu, Rong, et al.
Publicado: (2013)

SKIN NODULES AS A PRESENTING FEATURE OF DIFFUSE LARGE B-CELL GASTRIC LYMPHOMA
por: Suresh Attili, V Satya, et al.
Publicado: (2008)

Sintilimab combined with chidamide in the treatment of extranodal nature killer/T-cell lymphoma with secondary hemophagocytic lymphohistiocytosis: Two case reports and literature review
por: Xu, Qing-Yuan, et al.
Publicado: (2022)

Comparison of Chemotherapy Combined With Chidamide Versus Chemotherapy in the Frontline Treatment for Peripheral T-Cell Lymphoma
por: Wang, Jinni, et al.
Publicado: (2022)

Modified conditioning regimen with chidamide and high‐dose rituximab for triple‐hit lymphoma
por: Kang, Junnan, et al.
Publicado: (2021)

Secondary Cardiac Involvement From Diffuse Large B-cell Lymphoma: A Case Report
por: Akimana, Gloria, et al.
Publicado: (2022)

The Synergistic Anti-Tumor Activity of EZH2 Inhibitor SHR2554 and HDAC Inhibitor Chidamide through ORC1 Reduction of DNA Replication Process in Diffuse Large B Cell Lymphoma
por: Wang, Xing, et al.
Publicado: (2021)

Case of Gastric Diffuse Large B-Cell Lymphoma
por: Pirzada, Usman A., et al.
Publicado: (2019)

Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
por: Shi, Yuankai, et al.
Publicado: (2017)

The role of chidamide in the treatment of B-cell non-Hodgkin lymphoma: An updated systematic review
por: Ridwansyah, Hastono, et al.
Publicado: (2023)

Complications and outcomes in diffuse large B‐cell lymphoma with gastric lesions treated with R‐CHOP
por: Kadota, Tomohiro, et al.
Publicado: (2019)

Chidamide with PEL regimen (prednisone, etoposide, lenalidomide) for elderly or frail patients with relapsed/refractory diffuse large B‐Cell lymphoma ‐results of a single center, retrospective cohort in China
por: Wang, Yawen, et al.
Publicado: (2022)

Secondary Diffuse Large B-cell Lymphoma Mimicking Meningioma
por: Garcia-Grimshaw, Miguel, et al.
Publicado: (2019)

Chidamide triggers BTG1-mediated autophagy and reverses the chemotherapy resistance in the relapsed/refractory B-cell lymphoma
por: Xue, Kai, et al.
Publicado: (2021)

Chidamide combined with cyclophosphamide, doxorubicin, vincristine and prednisone in previously untreated patients with peripheral T-cell lymphoma
por: Gui, Lin, et al.
Publicado: (2021)

P1201: A REAL-WORLD STUDY OF CHIDAMIDE FOR PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA IN CHINA
por: Wang, Xin, et al.
Publicado: (2023)

Successful treatment with lenalidomide plus chidamide combination therapy in 3 heavily treated patients with non-Hodgkin lymphoma: Three cases report
por: Hu, Shaoxuan, et al.
Publicado: (2020)

Upregulation of CD22 by Chidamide promotes CAR T cells functionality
por: Yang, Xin, et al.
Publicado: (2021)

Multifocal Extranodal Involvement of Diffuse Large B-Cell Lymphoma
por: Cabuk, Devrim, et al.
Publicado: (2013)

Diffuse large B cell lymphoma of the cervix with rectal involvement
por: Igwe, Elena, et al.
Publicado: (2014)

Diffuse Large B-cell Lymphoma Involving the Skeletal Muscle
por: Harada, Ko, et al.
Publicado: (2017)

Diffuse Large B Cell Lymphoma with Cutaneous and Gastrointestinal Involvement
por: Kyaw, Aye-Mya-Mya, et al.
Publicado: (2022)

A Multi-Center, Real-World Study of Chidamide for Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas in China
por: Liu, Weiping, et al.
Publicado: (2021)

Therapeutic effect of chidamide on relapsed refractory angioimmunoblastic T-cell lymphoma: A case report and literature review
por: Jin, Jingxia, et al.
Publicado: (2018)

Aberrant JAK-STAT signaling-mediated chromatin remodeling impairs the sensitivity of NK/T-cell lymphoma to chidamide
por: Chen, Jinghong, et al.
Publicado: (2023)

A novel conditioning regimen of chidamide, cladribine, gemcitabine, and busulfan in the autologous stem cell transplantation of aggressive T-cell lymphoma
por: Zeng, Qiang, et al.
Publicado: (2023)

How I treat diffuse large B-cell lymphoma
por: Melchardt, T., et al.
Publicado: (2023)

Spontaneous perforation of primary gastric diffuse large B‐cell lymphoma
por: Daoud, Rahma, et al.
Publicado: (2023)

Primary Gastric Diffuse Large B-Cell Lymphoma: Prognostic Factors in the Immuno-Oncology Therapeutics Era
por: Bai, ZhiMin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mmjtkl10nsdab6bvdu33euoblr